Cirrhotic patients with thrombocytopenia have been treated with thrombopoietin (TPO) receptor agonists such as lusutrombopag a few weeks before invasive procedures [19, 20], markedly reducing the need for platelet transfusion. Here, THPO is linked to Thrombocytopenia.